BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Replimune Inc.
Boehringer Ingelheim
Hôpital NOVO
Seattle Children's Hospital
TScan Therapeutics, Inc.
Centre Hospitalier Universitaire de Nīmes
St. Jude Children's Research Hospital
Jemincare
Travera Inc
Fudan University
Marengo Therapeutics, Inc.
Verrica Pharmaceuticals Inc.
Vejle Hospital
Stanford University
Melanoma and Skin Cancer Trials Limited
Iovance Biotherapeutics, Inc.
Simcha IL-18, Inc.
R-Pharm
Philogen S.p.A.
Maastricht University Medical Center
Herlev Hospital
Kineta Inc.
Amgen
Genocea Biosciences, Inc.
Genocea Biosciences, Inc.
Sichuan University
Galderma R&D
Norfolk and Norwich University Hospitals NHS Foundation Trust
Polaris Group
MultiVir, Inc.
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC
Centre Hospitalier Universitaire de Saint Etienne
University of Chicago
MedImmune LLC
Stanford University
Bristol-Myers Squibb
Pfizer
National Institutes of Health Clinical Center (CC)